TDF2 study of pre-exposure prophylaxis (PrEP) among heterosexual men and women in Botswana : key facts

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

TDF2 study of pre-exposure prophylaxis (PrEP) among heterosexual men and women in Botswana : key facts

8/26/11
By Centers for Disease Control and Prevention (U.S.)

[PDF-98.02 KB]

English

Details You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)
Description:

Daily oral PrEP with a tablet containing tenofovir disoproxil fumarate and emtricitabine (TDF/FTC, known by the brand name Truvada®) was found to reduce the risk of acquiring HIV infection by roughly 63 percent in the study population overall.

In addition, researchers conducted a separate analysis to better understand the level of efficacy among trial participants believed to be taking study medications. This analysis excludes any HIV infections that occurred more than 30 days1 after a participant’s last reported drug dose, because those individuals could not have been taking study pills at the time of infection. These results indicate that TDF/FTC reduced the risk of HIV infection by 78 percent.
Subjects:

[+]

Anti-HIV Agents/therapeutic Use HIV Infections/prevention & Control Organophosphonates/therapeutic Use Truvada
Document Type:

Pamphlet (or booklet)
Genre:

Fact Sheet
Place as Subject:

Botswana
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:630506d34843409abb135d02ad0442f7caa3d500903de81c6044c06ccf5170e6
Download URL:

https://stacks.cdc.gov/view/cdc/23283/cdc_23283_DS1.pdf
File Type:

No Additional Files

More +

TDF2 study of pre-exposure prophylaxis (PrEP) among heterosexual men and women in Botswana : key facts

Details:

Supporting Files

You May Also Like